1. Arrow, K.J. 1963. “Uncertainty and the Welfare Economics of Medical Care” American Economic Review, Vol. 53, pp. 941–973.
2. Benjamin, C. et al. 1994. “Proceed with Care: Direct Predictive Testing for Huntington Disease” American Journal of Medical Genetics, Vol. 55, pp. 606–17.
3. Brunger, F. & Bassett, K. 1998. “Culture, Ethnicity and Genetic Testing” Socio-Ethical Issues in Human Genet-ics, B.M. Knoppers (Ed.), Cowansville, Quebec: Les Editions Yvon Blais Inc, pp. 7–42.
4. Burgess, M.M. & Hayden, M.R. 1996. “Patients’ Rights to Laboratory Data: Trinucleotide Repeat Length in Huntington Disease” American Journal of Medical Genetics, Vol. 62, pp. 6–9.
5. Burgess, M.M. et al. 1997. “Dilemmas of Anonymous Predictive Testing for Huntington Disease: Privacy vs. Optimal Care” American Journal of Medical Genetics, Vol. 71, pp. 197–201.